|
EIF2C3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.299310E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.223620E-03 |
| Normal-vs-Stage2 |
6.165800E-02 |
| Normal-vs-Stage3 |
2.720600E-01 |
| Normal-vs-Stage4 |
7.622200E-03 |
| Stage1-vs-Stage2 |
7.113600E-01 |
| Stage1-vs-Stage3 |
1.796770E-01 |
| Stage1-vs-Stage4 |
5.934600E-01 |
| Stage2-vs-Stage3 |
4.737800E-01 |
| Stage2-vs-Stage4 |
4.193800E-01 |
| Stage3-vs-Stage4 |
1.561620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.335200E-03 |
| Normal-vs-AfricanAmerican |
3.482000E-02 |
| Normal-vs-Asian |
2.280200E-01 |
| Caucasian-vs-AfricanAmerican |
7.368400E-01 |
| Caucasian-vs-Asian |
8.524400E-01 |
| AfricanAmerican-vs-Asian |
9.875000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.36419999999749E-05 |
| Normal-vs-Female |
5.481600E-01 |
| Male-vs-Female |
3.097500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.085450E-01 |
| Normal-vs-Extreme_Weight |
2.88709999995973E-06 |
| Normal-vs-Obese |
1.592170E-02 |
| Normal-vs-Extreme_Obese |
5.068000E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.704610E-01 |
| Normal_Weight-vs-Obese |
9.188000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.265200E-01 |
| Extreme_Weight-vs-Obese |
2.388200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.912600E-01 |
| Obese-vs-Extreme_Obese |
7.441200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.535800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.618080E-02 |
| Normal-vs-Age(61-80Yrs) |
7.79080000000709E-05 |
| Normal-vs-Age(81-100Yrs) |
2.469500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.246200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.498420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.307600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.751900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.813200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.621800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.88569999959709E-07 |
| Normal-VS-Type2 PRCC |
2.300000E-01 |
| Normal-VS-KIRP CIMP |
7.437800E-01 |
| Normal-VS-Unclassified PRCC |
3.579200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.557400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.062060E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.932080E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.312000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.113000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.406400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.763610E-02 |
| Normal-vs-N1 |
3.063000E-01 |
| Normal-vs-N2 |
3.933800E-02 |
| N0-vs-N1 |
2.862400E-01 |
| N0-vs-N2 |
5.115400E-01 |
| N1-vs-N2 |
2.482200E-01 |
|
|
